Trump is checked for swelling in legs and was diagnosed with a common condition in older adults

posted in: All news | 0

By DARLENE SUPERVILLE and LAURAN NEERGAARD, Associated Press

WASHINGTON (AP) — White House press secretary Karoline Leavitt on Thursday read a doctor’s letter about President Donald Trump that she said was intended to dispel health concerns about the swelling in his ankles and a makeup-covered hand.

Leavitt said Trump noticed “mild swelling” in his lower legs and was evaluated by the White House medical unit.

She said the tests showed “no evidence of deep vein thrombosis or arterial disease,” but that Trump has “chronic venous insufficiency,” a fairly common condition in older adults when little valves inside the veins that normally help move blood against gravity up the legs gradually lose the ability to work properly.

Leavitt said the issue is common in people older than age 70. Trump turned 79 last month.

Related Articles


‘Fear is the tool of a tyrant,’ fired federal prosecutor Maurene Comey tells colleagues


The House is poised to OK Trump’s $9 billion cut to public broadcasting and foreign aid


State Department layoffs affect key Trump priorities like intelligence, energy and China


Consultant, claiming White House backing, called Colorado clerks to gain access to voting machines


Trump administration hands over Medicaid recipients’ personal data, including addresses, to ICE

People often are advised to lose weight, walk for exercise and elevate their legs periodically, and some may be advised to wear compression stockings. Severe cases over time can lead to complications including lower leg sores called ulcers. Blood clots are one cause, but Leavitt said that was tested for and ruled out.

She also said bruising on Trump’s hand that has been covered up by makeup is “consistent” with irritation from his “frequent handshaking and the use of aspirin.”

Leavitt said “the president remains in excellent health.”

She promised to make the doctor’s letter public.

Steve Miller Band cancels Minnesota State Fair Grandstand show due to climate change

posted in: All news | 0

Citing climate change, the Steve Miller Band has canceled their upcoming 31-date North American tour, which includes an Aug. 28 stop at the Minnesota State Fair Grandstand.

“The combination of extreme heat, unpredictable flooding, tornadoes, hurricanes and massive forest fires make these risks for you our audience, the band and the crew unacceptable. So …You can blame it on the weather… The tour is canceled,” reads an announcement on the band’s website. “Don’t know where, don’t know when… We hope to see you all again.”

Ticket buyers who purchased from Etix or the Minnesota State Fair using a credit card will automatically receive a refund. Others should return to the point of purchase for a refund.

State Fair officials learned the news Wednesday evening and have yet to announce a replacement act.

While it’s not unusual for a tour to cancel shows due to weather issues, Variety notes this may be the first time an entire tour was canceled due to climate change.

Led by 81-year-old Milwaukee native Steve Miller, the group released seven albums to little commercial success, but broke through to the mainstream with 1973’s “The Joker.” The band’s biggest hits include “Take the Money and Run,” “Fly Like an Eagle,” “Jet Airliner,” “Rock’n Me” and “Abracadabra.”

Miller earned headlines in 2016 when he was nominated to the Rock Hall as a solo artist. He told Rolling Stone: “I kind of enjoyed having people complain that I wasn’t in the Rock and Roll Hall of Fame more than I think I’ll like being in it.” After the induction ceremony, Miller further vented to the magazine in an expletive-filled rant about the ceremony and the music business in general.

The Minnesota State Fair runs from Aug. 21 through Sept. 1.

Related Articles


‘Hot in Herre’ hitmaker Nelly to headline the Minnesota State Fair Grandstand


What to know if you’re headed to the Minnesota Yacht Club Festival


Concert review: Belcher’s violin elegant and expressive in Minnesota Orchestra’s German Romances


Paul McCartney to play his first local show in nearly a decade in October


Raihala: Four aging rock acts with upcoming Twin Cities shows on the books

Settlement reached in investors’ lawsuit against Meta CEO Mark Zuckerberg and other company leaders

posted in: All news | 0

By MINGSON LAU, Associated Press

WILMINGTON, Del. (AP) — A settlement was announced Thursday in court in a class action investors’ lawsuit against Meta CEO Mark Zuckerberg and current and former company leaders over claims stemming from the privacy scandal involving the Cambridge Analytica political consulting firm.

The suit had sought billions of dollars in reimbursement for fines and legal costs. No details on the settlement were shared when it was announced in Delaware’s Court of Chancery at the start of what would have been the second day of trial, at which point nothing related to the settlement had been filed with the court.

The attorneys involved left court without commenting. A communications representative from Meta said the company had no comment.

Related Articles


‘Fear is the tool of a tyrant,’ fired federal prosecutor Maurene Comey tells colleagues


Ground squirrels are taking over a North Dakota city and officials are not amused


Can artificial reefs in Lake Michigan slow erosion and boost fish population? Researchers aim to find out.


An Idaho judge has lifted a sweeping gag order in Bryan Kohberger’s quadruple murder case


Why is the Los Angeles Innocence Project trying to free Scott Peterson?

Investors had alleged in the lawsuit that Meta did not fully disclose the risks to Facebook users that their personal information would be misused by Cambridge Analytica, a firm that supported Donald Trump’s successful Republican presidential campaign in 2016. Shareholders say Facebook officials repeatedly violated a 2012 consent order with the Federal Trade Commission under which Facebook agreed to stop collecting and sharing personal data without users’ consent.

Facebook later sold user data to commercial partners in direct violation of the consent order and removed disclosures from privacy settings that were required under consent order, the lawsuit alleged.

Facebook agreed to pay a $5.1 billion penalty to settle FTC charges in the fallout. The social media giant also faced significant fines in Europe and reached a $725 million privacy settlement with users.

Shareholders wanted Zuckerberg and others to reimburse Meta an estimated $8 billion or more for the FTC fine and other legal costs.

Zuckerberg and former Chief Operating Officer Sheryl Sandberg had been expected to testify. Other current and former board members, including billionaires Marc Andreessen and Peter Thiel, were also included as defendants.

Earlier this year, Sandberg was sanctioned for deleting emails from her personal account related to the Cambridge Analytica investigation. Jeffrey Zients, who served as an outside director from 2018 to 2020, avoided sanctions in the same case because his role made it less likely he had access to relevant information.

Testifying on the first day of this lawsuit, Zients said he had supported the FTC settlement for which shareholders were seeking reimbursement.

Associated Press reporter Barbara Ortutay in San Francisco contributed to this report.

Researchers try new ways of preserving more hearts for transplants

posted in: All news | 0

By LAURAN NEERGAARD, AP Medical Writer

WASHINGTON (AP) — Two university hospitals are pioneering new ways to expand lifesaving heart transplants for adults and babies — advances that could help recover would-be heart donations that too often go unused.

The new research aims to overcome barriers for using organs from someone who dies when their heart stops. Called DCD, or donation after circulatory death, it involves a controversial recovery technique or the use of expensive machines.

Surgeons at Duke and Vanderbilt universities reported Wednesday that they’ve separately devised simpler approaches to retrieve those hearts. In the New England Journal of Medicine, they described successfully transplanting hearts to a 3-month-old infant at Duke and three men at Vanderbilt.

“These DCD hearts work just as well as hearts from brain-dead donors,” said Vanderbilt lead author Dr. Aaron M. Williams.

How hearts are saved for donation

Most transplanted hearts come from donors who are brain dead. In those situations, the body is left on a ventilator that keeps the heart beating until the organs are removed.

Circulatory death occurs when someone has a nonsurvivable brain injury but because all brain function hasn’t ceased, the family decides to withdraw life support and the heart stops. That means organs can spend a while without oxygen before being recovered, a time lag usually doable for kidneys and other organs but that can raise questions about the quality of hearts.

To counter damage and determine whether DCD organs are usable, surgeons can pump blood and oxygen to the deceased donor’s abdominal and chest organs — after clamping off access to the brain. But it’s ethically controversial to artificially restore circulation even temporarily and some hospitals prohibit that technique, called normothermic regional perfusion, or NRP.

Another option is to “reanimate” DCD organs in a machine that pumps blood and nutrients on the way to the transplant hospital. The machines are expensive and complex, and Duke’s Dr. Joseph Turek said the devices can’t be used for young children’s small hearts — the age group with the most dire need.

New ways of preserving hearts

Turek’s team found a middle ground: Remove the heart and attach some tubes of oxygen and blood to briefly assess its ability to function — not in a machine but on a sterile table in the operating room.

They practiced with piglets. Then came the real test. At another hospital, life support was about to be withdrawn from a 1-month-old whose family wanted to donate — and who would be a good match for a 3-month-old Duke patient in desperate need of a new heart. The other hospital didn’t allow the controversial NRP recovery technique but let Turek’s team test the experimental alternative.

It took just five minutes to tell “the coronary arteries are filling well, it’s pink, it’s beating,” Turek said. The team promptly put the little heart on ice and raced it back to Duke.

Vanderbilt’s system is even simpler: Infuse the heart with a nutrient-rich, cold preservative solution before removing it from the donor’s body, similar to how hearts from brain-dead donors are handled.

That “replenishes the nutrients that are depleted during the dying process and helps protect it for transport,” Williams explained, adding that Vanderbilt has performed about 25 such transplants so far. “Our view is you don’t necessarily need to reanimate the heart.”

More donated hearts are needed

There’s a huge need for more transplantable hearts. Hundreds of thousands of adults suffer from advanced heart failure, yet many are never even offered a transplant because of the organ shortage.

Every year about 700 children in the U.S. are added to the transplant list for a new heart and about 20% die waiting. Turek said infants are at particular risk.

Related Articles


Juul can continue selling its tobacco and menthol e-cigarettes, FDA says


Healthy babies born in Britain after scientists used DNA from three people to avoid genetic disease


Congress targeted Planned Parenthood for defunding, but also caught a Maine health care provider


Stillwater: Silver Sobriety marks 10 years with new location, new executive director


RFK Jr. and other Trump officials embrace psychedelics after FDA setback

Last year, people whose lives ended via circulatory death made up 43% of the nation’s deceased donors — but just 793 of the 4,572 heart transplants.

That’s why many specialists say finding ways to use more of those hearts is crucial. The new studies are small and early-stage but promising, said Brendan Parent of NYU Langone Health, who directs transplant ethics and policy research.

“Innovation to find ways to recover organs successfully after circulatory death are essential for reducing the organ shortage,” he said.

If alternatives pan out, “I absolutely think that cardiac programs will be thrilled, especially at hospitals that have rejected NRP.”

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.